Horizon Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.05M Buy
+110,112
New +$6.05M 0.1% 172
2022
Q4
Sell
-5,469
Closed -$464K 533
2022
Q3
$464K Buy
+5,469
New +$464K 0.01% 337
2022
Q2
Sell
-9,688
Closed -$747K 466
2022
Q1
$747K Buy
9,688
+23
+0.2% +$1.77K 0.02% 271
2021
Q4
$854K Buy
9,665
+606
+7% +$53.5K 0.03% 229
2021
Q3
$700K Sell
9,059
-874
-9% -$67.5K 0.02% 256
2021
Q2
$829K Buy
9,933
+6,924
+230% +$578K 0.02% 236
2021
Q1
$227K Sell
3,009
-720
-19% -$54.3K 0.01% 404
2020
Q4
$327K Buy
+3,729
New +$327K 0.37% 71